Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-27 @ 3:14 AM
Study NCT ID:
NCT00551733
Status:
TERMINATED
Last Update Posted:
2020-10-05
First Post:
2007-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Sponsor:
CTI BioPharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CTI-PGT-07-00400
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None